Entrepreneurs rarely face the challenge of having too few ideas. In fact, like most entrepreneurs and business leaders you probably have a multitude of great ideas for growing your own business. Your biggest challenge may be figuring out which of all the alternatives is the best way to get from where you are now to […]

Read More

Capstone’s State of Midmarket M&A Q1-Q3 2014 Update indicates a steady growth in midmarket mergers and acquisitions. We surveyed midmarket executives from multiple industries to learn how the first nine months of 2014 matched expectations from 2013, and to indicate any new trends in midmarket M&A. The survey was conducted in October 2014, and follows a […]

Read More

In the first nine months of 2014, US transactions made up 51% of global mergers and acquisitions indicating confidence in the strength of the US economy. In Europe, cash-stuffed German companies looked to international markets, especially the US, to drive growth. Recent deals include Siemens acquisition of Dresser Rand for $7.6 billion, Merck of Germany’s […]

Read More

Capstone again is teaming with Georgetown Alumni Career Services to present a series of webinars on growing through mergers and acquisitions. Capstone and Georgetown initially partnered in February when Capstone Managing Director John Dearing presented “Proactive Growth Through Acquisitions.” Due to the positive feedback from Georgetown alumni and their desire to learn more, John has […]

Read More

Capstone CEO David Braun will present “Strategic Alliances, Joint Ventures and M&A – the Route to Success?” at the 2014 European Base Oil & Lubricants Summit in Alicante, Spain on September 18. The two-day conference brings together leading executives and experts in the lubricant and base oil industry from established Western Europe and U.S. markets […]

Read More

“The danger with a mergers-and-acquisitions boom is that chief executives could allow themselves to get carried away by the thrill of the hunt, reducing their focus on internal investment projects that might have a better chance of bearing fruit,” says the New York Time’s Dealbook column. M&A activity has reached record highs and shows no […]

Read More

Too many attempted acquisitions collapse before they are consummated. Don’t let this happen to you! Join our webinar and equip yourself to close the deal. Did you know that $390 billion worth of deals have been withdrawn in 2014? After months of preparation these acquisitions fell apart, post letter of intent. Rather than scare you […]

Read More

Valeant Pharmaceuticals International is determined to grow through acquisitions.  Already actively pursuing a deal with Allergan, the maker of Botox, Valeant is reportedly seeking another contact lens company. CEO Michael Pearson said the company “will not be content to remain the No. 4 global player in the contact lens industry.” Valeant has a history of […]

Read More

M&A activity was on the rise in the first six months of 2014. Global M&A increased 73 percent to $1.77  trillion and  Midmarket M&A increased 18 percent to $399.4 billion. Check out our infographic for a snapshot on Global Mergers and Acquisitions in 1H 2014. Click on the image for a closer look. Feature Photo […]

Read More

The polyolefins industry, like so many others, is evolving significantly. Growth in emerging markets and Asia has skyrocketed while European and North American markets have matured. Last week I was invited to speak at the Future of Polyolefins Conference 2014 in Dusseldorf, Germany, where top executives from key industry players such as Borealis AG and […]

Read More

M&A activity is at the highest level it’s been since before the recession in 2007. We’ve been talking about an uptick in deal activity since last year and now we’re finally seeing real traction. So far in 2014, there have been $1.7 trillion in deals. In Q1 2014, US deal value was up 56% and […]

Read More

Pharmaceutical companies are using acquisition to become “pointy,” or more focused. Two recent examples are Bayer and Merck.  Bayer is focusing on over the counter medications by acquiring Merck’s consumer care business for $14.2 billion. On the other hand, Merck has become more streamlined through divestment. As I’ve mentioned before, although divestment means becoming smaller, […]

Read More

Private equity investors and strategic buyers are enthusiastic about 2014. Of the U.S. executives polled recently by EY Americas Transaction Advisory Services, 41 % said they expect to pursue at least one acquisition in 2014, compared with only 23 % polled at the end of 2012.  Uncertainty in regulation remains one of the biggest challenges […]

Read More

This is the third part in a series addressing current and expected viewpoints on M&A from across a number of professionally relevant sources. Read parts one and two of our Midmarket M&A Analysis.  Industries that showed strong growth in early-stage activity in Q3 2013 included the consumer, life sciences, and telecommunications, media and entertainment (TME) sectors.  Additionally […]

Read More

This is the second part in a series addressing current and expected viewpoints on M&A from across a number of professionally relevant sources. For part one, read Midmarket M&A Analysis: 2013 to 2014. 2013 saw a number of announced large-cap deals aimed at consolidating market positions and facilitating growth into new regions. Most notable has been Verizon […]

Read More

Following the credit crisis of the last few years and the resulting substantial decline in M&A activity, the subject of a revival in M&A activity has been much anticipated and discussed by industry participants and observers. This week, we will release a series of blog posts providing a synthesis of M&A sentiment and opinion, incorporating […]

Read More

January 13, 2014 (McLean, VA) – Capstone Strategic, Inc., a leading management consulting firm specializing in strategic growth, announced today that Michelman and Maruyoshi Chemical have entered into a joint venture, Maruyoshi Michelman Co. Ltd. Michelman is a global developer of water-based coatings headquartered in Cincinnati, OH. Maruyoshi is a specialty waterborne polyolefin emulsions and chemical […]

Read More

In performing due diligence, I recommend you look not only for risks but also for opportunities. That’s how I approach due diligence for our Capstone clients.  As we examine the seller’s operations and books, we place every new discovery in one of three color-coded “buckets:” Red Bucket: Deal Changers. This is information that materially alters […]

Read More

Many executives engaged in M&A believe in creating a long list of acquisition prospects. However, the goal of your M&A process should be to find the right companies. Obviously, it’s good to fill your pipeline with prospects, but you want to be sure these prospects match your strategic criteria. What good is a long list […]

Read More

Last week, I wrote about the importance of self-exploration. To begin your journey of self-exploration, here are seven strategic questions you may find helpful: 1)     What business are we in? 2)     What is our core competency? 3)     What are we not? 4)     Where is our pain? 5)     What are our dreams? 6)     What is our […]

Read More